RAD51 and cancer: Finally, RAD51's pan‐cancer progression‐free interval (PFI) analysis predicted poor prognosis in 10 cancers: OSCC, PRAD, LUAD, LGG, LIHC, KIRP, MESO, uveal melanoma (UVM), PAAD and PCPG, with statistical significance (p < 0.05) (Figure 2F).